Pre-op MRI of margins predicts rectal cancer outcomes

Pre-op MRI of margins predicts rectal cancer outcomes

(HealthDay)—Preoperative high-resolution magnetic resonance imaging (MRI) assessment of circumferential resection margin (CRM) status predicts survival and other disease progression outcomes in patients with rectal cancer, according to a study published online Nov. 25 in the Journal of Clinical Oncology.

Fiona G.M. Taylor, from Mayday University Hospital in Croydon, U.K., and colleagues conducted a follow-up study in 374 patients with . Preoperative high-resolution pelvic MRIs were used to assess CRM, and the relationship of MRI assessment and outcomes were evaluated.

The researchers found that five-year overall survival (OS) was 62.2 percent in patients with MRI-clear CRM compared to 42.2 percent in patients with MRI-involved CRM (hazard ratio, 1.97). Disease-free survival (DFS) at five years was 67.2 percent for MRI-clear CRM versus 47.3 percent for MRI-involved CRM (hazard ratio, 1.65). For MRI-involved CRM, local recurrence (LR) was 3.50. In multivariate analysis, MRI-involved CRM was the only preoperative staging parameter that remained significant for OS, DFS, and LR.

"High-resolution MRI preoperative assessment of CRM status is superior to American Joint Committee on Cancer TNM-based criteria for assessing risk of LR, DFS, and OS," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

MRI predicts survival in locally advanced rectal cancer

Aug 29, 2011

A new study has shown that magnetic resonance imaging (MRI) used to evaluate responses to pre-surgery (neo-adjuvant) chemotherapy or radiation may predict survival among patients with advanced rectal cancer. The findings ...

High-dose rhBMP linked to increased incidence of cancer

Oct 04, 2013

(HealthDay)—Patients receiving high-dose recombinant human bone morphogenetic protein-2 (rhBMP-2) as part of spine surgery have an increased risk of cancer and may be at risk for major complications, according ...

Recommended for you

Aspirin may lower the risk for aggressive prostate cancer

4 hours ago

Use of aspirin and/or other non-steroidal anti-inflammatory drugs (NSAIDs) was associated with a reduced risk for aggressive prostate cancer in men who had elevated prostate specific antigen (PSA) and a negative biopsy prior ...

User comments